Perspective Therapeutics Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Perspective Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $12.93. The average 1-year stock price forecast is 341.30% higher than the current stock price, while the lowest is $6.00 (+104.78%) and the highest is $18 (+514.33%).

Price Target: $12.93 (+341.30%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$12.93	$13	$18
Change	+104.78%	+341.30%	+343.69%	+514.33%

Analyst Ratings

The average analyst rating for Perspective Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	12	12	12	12	12	12
Buy	1	2	2	2	2	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	15	15	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Biren Amin Piper Sandler	Piper Sandler	Buy Maintains $16	Buy	Maintains	$16	+446.08%	Jun 1, 2026
Jeff Jones Oppenheimer	Oppenheimer	Buy Reiterates $13	Buy	Reiterates	$13	+343.69%	Jun 1, 2026
Robert Burns H.C. Wainwright	H.C. Wainwright	Buy Reiterates $13	Buy	Reiterates	$13	+343.69%	Jun 1, 2026
Alec Stranahan Bank of America Securities	Bank of America Securities	Hold Maintains $6	Hold	Maintains	$6	+104.78%	Jun 1, 2026
Oliver McCammon LifeSci Capital	LifeSci Capital	Buy Maintains $15	Buy	Maintains	$15	+411.95%	May 16, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

410.60K

from 884.00K

-53.55%

from 884.00K

Revenue Next Year

478.45K

from 410.60K

16.52%

from 410.60K

EPS This Year

-1.16

from -1.40

EPS Next Year

-1.15

from -1.16

Fiscal Year	FY 2022	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2022	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	5.42M	1.43M	1.45M	884.00K	410.60K
Revenue Growth	-	-	-73.52%	1.40%	-39.20%	-53.55%
Gross Profit	-	2.37M	-18.91M	-40.18M	-83.33M	225.83K
Gross Margin	-	43.71%	-1,318.62%	-2,763.69%	-9,426.58%	55.00%
Operating Income	-6.42M	-8.80M	-40.94M	-66.80M	-113.56M	-125.55M
Net Income	-7.27M	-10.76M	-46.51M	-79.28M	-103.12M	-121.00M
EPS	-	-	-	-	-1.40	-1.16
Free Cash Flow	-2.73M	-	-8.54M	-83.66M	-60.37M	-114.71M
No. Analysts	-	-	-	-	-	14

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	1.1M
Avg	410,600
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	20.0%
Avg	-53.6%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-1.16
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-